Carregant...
Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of cyclin‐dependent kinase (CDK) 4/6 inhibitors in the treatment of patients with hormone receptor‐positive advanced breast cancer.
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491121/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012919 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|